AAAAAA
Results:
1-7
|
Results: 7
Authors:
Cullen, JM
Ll, DH
Brown, C
Eisenberg, EJ
Cundy, KC
Wolfe, J
Toole, J
Gibbs, C
Citation: Jm. Cullen et al., Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks, ANTIM AG CH, 45(10), 2001, pp. 2740-2745
Authors:
Sweeny, DJ
Lynch, G
Bidgood, AM
Lew, W
Wang, KY
Cundy, KC
Citation: Dj. Sweeny et al., Metabolism of the influenza neuraminidase inhibitor prodrug oseltamivir inthe rat, DRUG META D, 28(7), 2000, pp. 737-741
Authors:
Hughes, WT
Shenep, JL
Rodman, JH
Fridland, A
Willoughby, R
Blanchard, S
Purdue, L
Coakley, DF
Cundy, KC
Culnane, M
Zimmer, B
Burchett, S
Read, JS
Citation: Wt. Hughes et al., Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type1, ANTIM AG CH, 44(4), 2000, pp. 1041-1046
Authors:
Oliyai, R
Shaw, JP
Sueoka-Lennen, CM
Cundy, KC
Arimilli, MN
Jones, RJ
Lee, WA
Citation: R. Oliyai et al., Aryl ester prodrugs of cyclic HPMPC. I: PhysicochemicaI characterization and in vitro biological stability, PHARM RES, 16(11), 1999, pp. 1687-1693
Authors:
Cundy, KC
Citation: Kc. Cundy, Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir, CLIN PHARMA, 36(2), 1999, pp. 127-143
Authors:
Cundy, KC
Barditch-Crovo, P
Petty, BG
Ruby, A
Redpath, M
Jaffe, HS
Lietman, PS
Citation: Kc. Cundy et al., Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients, ANTIM AG CH, 43(2), 1999, pp. 271-277
Authors:
Brody, SR
Humphreys, MH
Gambertoglio, JG
Schoenfeld, P
Cundy, KC
Aweeka, FT
Citation: Sr. Brody et al., Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis, CLIN PHARM, 65(1), 1999, pp. 21-28
Risultati:
1-7
|